OpenVSafe by OpenVAERS
Search V-safe

B5Q-24812-00596

2 vaccinations 5 coded responses 21 check-ins 5 free-text entries 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
631 / MO
Registered
2021-11-13
Relationship
Child or adolescent in my care
Guardian
XXC-19355-68301
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-12
    Dose 1 — Pfizer-BioNTech
  2. 2021-11-13
    Registered in v-safe
  3. 2021-11-13
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-11-14
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  5. 2021-11-17
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  6. 2021-11-18
    Health check-in — days 1–6 daily, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  7. 2021-11-19
    Health check-in — 7 day, dose 1, dependent
    Feeling: Good · None
    Adult check-in
  8. 2021-11-26
    Survey response — 14 day, dose 1, dependent
    MedDRA: Feeling abnormal, Nasopharyngitis — Feeling: Fair
    MedDRA releases: 2024-11 · check-in answers available
  9. 2021-12-03
    Dose 2 — Pfizer-BioNTech
  10. 2021-12-03
    Survey response — 0 day, dose 2, dependent
    MedDRA: No adverse event — Feeling: Fair · Site: Pain
    MedDRA releases: 2024-11 · check-in answers available
  11. 2021-12-04
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Fair · Site: Pain · None
    Adult check-in
  12. 2021-12-05
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  13. 2021-12-07
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  14. 2021-12-08
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  15. 2021-12-09
    Health check-in — days 1–6 daily, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  16. 2021-12-12
    Health check-in — 7 day, dose 2, dependent
    Feeling: Good · None
    Adult check-in
  17. 2021-12-17
    Health check-in — 14 day, dose 2, dependent
    Feeling: Good
    Adult check-in
  18. 2021-12-24
    Health check-in — 21 day, dose 2, dependent
    Feeling: Good
    Adult check-in
  19. 2021-12-31
    Health check-in — 28 day, dose 2, dependent
    Feeling: Good
    Adult check-in
  20. 2022-01-09
    Health check-in — 35 day, dose 2, dependent
    Feeling: Good
    Adult check-in
  21. 2022-01-15
    Health check-in — 42 day, dose 2, dependent
    Feeling: Good
    Adult check-in
  22. 2022-03-06
    Survey response — 3 month, dose 2, dependent
    MedDRA: Nasopharyngitis — Feeling: Good
    MedDRA releases: 2024-11 · check-in answers available
  23. 2022-06-05
    Survey response — 6 month, dose 2, dependent
    MedDRA: Sinusitis — Feeling: Good
    MedDRA releases: 2024-11 · check-in answers available
  24. 2022-12-05
    Survey response — 12 month, dose 2, dependent
    MedDRA: Ear infection, Nasopharyngitis, Sinusitis — Feeling: Fair · Be unable to work or attend school
    MedDRA releases: 2024-11 · check-in answers available

Vaccinations

DoseDateManufacturerCo-administered
12021-11-12Pfizer-BioNTech No
22021-12-03Pfizer-BioNTech No

Free text

Release 10

Symptoms: She has developed a cold, and is pretty miserable.

Systemic reaction (other): None yet

Release 11

Symptoms: Just a cold

Symptoms: Sinus infection

Release 12

Symptoms: Sinus infection, ear infection and cold

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDEar infection · · ✓
SDFeeling abnormal · · ✓
SDNasopharyngitis · · ✓
SDSinusitis · · ✓
SRONo adverse event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release